为啥5元流感疫苗打不动，200元流感药抢着要？

Core Viewpoint - The article highlights the stark contrast between the low sales of flu vaccines and the high sales of flu medications in China, primarily due to widespread vaccine hesitancy among the population, including healthcare professionals [2][10]. Vaccine Market Analysis - The annual sales of flu vaccines from three leading companies in China—Hualan Biological (10.7 billion), Zhonghui Biological (2.6 billion), and Jindike (808 million)—total approximately 1.4 billion, which is only about half of the annual sales of flu medication from Dongyangguang Pharmaceutical, which stands at around 2.6 billion [1][11]. - The flu vaccine uptake in China is extremely low, with a reported vaccination rate of only about 3%, significantly below global averages [11][12]. Vaccine Hesitancy Factors - Vaccine hesitancy is attributed to several factors, including doubts about vaccine safety and effectiveness, the perception that flu vaccines do not prevent infection due to the virus's constant mutation, and a preference for immediate medication over preventive measures [6][8]. - A study indicated that over half of social media users exhibit flu vaccine hesitancy, primarily due to distrust in vaccine efficacy and safety, exacerbated by misinformation [7][8]. Healthcare Professionals' Attitudes - Many healthcare professionals, including doctors, show reluctance to receive flu vaccinations, with some citing personal experiences and a belief in their own immunity as reasons for not vaccinating themselves or their children [3][4][6]. - A significant number of medical staff do not participate in vaccination programs, even when offered for free, indicating a broader issue of vaccine acceptance within the healthcare community [4][5]. Public Health Implications - The low vaccination rates have led to preventable illnesses and deaths, with estimates suggesting over 200,000 excess deaths annually due to flu-related complications in China [11]. - Recent initiatives by health authorities aim to improve vaccination rates by integrating flu vaccine prescriptions into routine medical care and encouraging healthcare workers to lead by example [12].